Clinical Trial: Plozasiran Prevents Recurrent Pancreatitis in Adults With Very Severe Hypertriglyceridemia—Results of a Post Hoc Analysis of the Phase 3 PALISADE Study

Documenti analoghi

• Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia—Authors' Reply
  di: Maral Amangurbanova, et al.
  Pubblicazione: (2024)
• Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol—Authors' Reply
  di: Federica Tavaglione, et al.
  Pubblicazione: (2025)
• Letter: Safety and Tolerability of Injectable Extended‐Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease—Authors' Reply
  di: Luis Antonio Díaz, et al.
  Pubblicazione: (2025)
• A Message From the Editors
  di: Colin W. Howden, et al.
  Pubblicazione: (2024)
• Research Communication: Real‐World Clinical Experience With Seladelpar in Primary Biliary Cholangitis
  di: Selena Z. Kuo, et al.
  Pubblicazione: (2025)